Key statistics
On Thursday, Iovance Biotherapeutics Inc (2LB:DEU) closed at 7.91, 70.41% above the 52 week low of 4.64 set on Nov 22, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 7.64 |
---|---|
High | 7.97 |
Low | 7.60 |
Bid | 7.75 |
Offer | 7.99 |
Previous close | 7.74 |
Average volume | 8.71k |
---|---|
Shares outstanding | 304.78m |
Free float | 276.56m |
P/E (TTM) | -- |
Market cap | 2.51bn USD |
EPS (TTM) | -1.50 USD |
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
- Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024
- Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024
- Iovance Biotherapeutics to Present at Upcoming Conferences
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2024
- Iovance Biotherapeutics to Host Second Quarter and First Half 2024 Financial Results Conference Call and Webcast on Thursday, August 8, 2024
- Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma
- Iovance Biotherapeutics to Present at Upcoming Conferences and Events
- Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting
- Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates
More ▼